nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antiviral evaluation of thionucleosides
|
|
|
1996 |
1 |
3 |
p. 123- 1 p. |
artikel |
2 |
Asymmetric synthesis of pyrrolidinoisoquinoline derivatives
|
|
|
1996 |
1 |
3 |
p. 125- 1 p. |
artikel |
3 |
Case histories in drug discovery
|
Lloyd, Andrew W. |
|
1996 |
1 |
3 |
p. 90-91 2 p. |
artikel |
4 |
Corticotropin-releasing factor and Alzheimer's disease
|
|
|
1996 |
1 |
3 |
p. 127- 1 p. |
artikel |
5 |
COX-2 inhibitors
|
|
|
1996 |
1 |
3 |
p. 122-123 2 p. |
artikel |
6 |
Devolved drug discovery and the virtual research centre
|
Cavalla, David |
|
1996 |
1 |
3 |
p. 87- 1 p. |
artikel |
7 |
Devolved drug discovery — the story continues
|
Hughes, David |
|
1996 |
1 |
3 |
p. 88- 1 p. |
artikel |
8 |
DNA mimic of bacterial tRNA
|
|
|
1996 |
1 |
3 |
p. 127- 1 p. |
artikel |
9 |
Dopamine D1 receptor
|
Wallace, Robert W. |
|
1996 |
1 |
3 |
p. 127- 1 p. |
artikel |
10 |
Emerging molecular targets
|
|
|
1996 |
1 |
3 |
p. 126-127 2 p. |
artikel |
11 |
Genome revolution: impact on drug discovery and development
|
|
|
1996 |
1 |
3 |
p. 126- 1 p. |
artikel |
12 |
HIV-1 reverse transcriptase inhibitors
|
|
|
1996 |
1 |
3 |
p. 122- 1 p. |
artikel |
13 |
Indirect enzymic phosphorylation
|
|
|
1996 |
1 |
3 |
p. 124- 1 p. |
artikel |
14 |
Leukotriene B4 receptor antagonist
|
|
|
1996 |
1 |
3 |
p. 123- 1 p. |
artikel |
15 |
Metabotropic glutamate receptors: potential drug targets
|
Knöpfel, Thomas |
|
1996 |
1 |
3 |
p. 103-108 6 p. |
artikel |
16 |
New therapeutic agents for the treatment of insulin resistance and NIDDM
|
Turner, Nicholas C. |
|
1996 |
1 |
3 |
p. 109-116 8 p. |
artikel |
17 |
NIH patent profile
|
Hughes, David |
|
1996 |
1 |
3 |
p. 92- 1 p. |
artikel |
18 |
Novel cell adhesion inhibitors
|
|
|
1996 |
1 |
3 |
p. 123- 1 p. |
artikel |
19 |
Novel non-indole 5-HT10 agonists
|
|
|
1996 |
1 |
3 |
p. 123- 1 p. |
artikel |
20 |
Novel optically pure triols
|
|
|
1996 |
1 |
3 |
p. 124- 1 p. |
artikel |
21 |
Novel oxytocin antagonist
|
|
|
1996 |
1 |
3 |
p. 122- 1 p. |
artikel |
22 |
Novel targets for drug discovery
|
Wallace, Robert W. |
|
1996 |
1 |
3 |
p. 91-92 2 p. |
artikel |
23 |
PAF synthesis
|
|
|
1996 |
1 |
3 |
p. 125- 1 p. |
artikel |
24 |
Preparation of 4-substituted 2-phenyloxazole-5-carboxylates
|
|
|
1996 |
1 |
3 |
p. 125- 1 p. |
artikel |
25 |
Reduction of lactones
|
|
|
1996 |
1 |
3 |
p. 124- 1 p. |
artikel |
26 |
Ribozymes as therapeutic agents
|
Joseph Marr, J. |
|
1996 |
1 |
3 |
p. 94-102 9 p. |
artikel |
27 |
Society for biomolecular screening
|
Giordano, Christine |
|
1996 |
1 |
3 |
p. 93- 1 p. |
artikel |
28 |
Synthesis of phosphonate and thiophosphonate esters and amides
|
|
|
1996 |
1 |
3 |
p. 125- 1 p. |
artikel |
29 |
Topoisomerase II inhibitors
|
|
|
1996 |
1 |
3 |
p. 122- 1 p. |
artikel |
30 |
What place for R&D in tomorrow's drug industry?
|
Johnson, Gary |
|
1996 |
1 |
3 |
p. 117-121 5 p. |
artikel |